Brian Goff Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Brian Goff is of Intellia Therapeutics, Inc.. Currently has a direct ownership of 23,409 shares of NTLA, which is worth approximately $224,024. The most recent transaction as insider was on Jun 11, 2025, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K
51.92% 3M change
51.92% 12M change
Total Value Held $224,024

Brian Goff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
8,000 Added 25.47%
23,409 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
15,409 Added 50.0%
15,409 Common Stock

Also insider at

ALXN
ALEXION PHARMACEUTICALS, INC.
EVP & Chief Commercial Officer
AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Chief Executive Officer
BG

Brian Goff

Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA